Search Results

HER2 Low Expression in Primary Male Breast Cancer

• Authors : Nobbe, Katleen; Erices-Leclercq, Melanie; Foerster, Frank

• Source: Breast Cancer: Targets and Therapy. March 31, 2024, Vol. 16, p141, 7 p.

Record details

The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer

• Authors : Liu, Luyao; Xiao, Wang; Zhang, Chaojie

• Source: International Journal of General Medicine. April 30, 2024, Vol. 17, p1233, 19 p.

Record details

CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1

• Authors : Zhu, Xudong; Yu, Jiahui; Ai, Fulu

• Source: Breast Cancer: Targets and Therapy. December 31, 2023, Vol. 15, p967, 18 p.

Record details

A Comprehensive Model Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging Can Better Predict the Preoperative Histological Grade of Breast Cancer Than a Radiomics Model

• Authors : Wu, Yitian; Pan, Weixing; Wang, Lingxia

• Source: Breast Cancer: Targets and Therapy. October 31, 2023, Vol. 15, p709, 12 p.

Record details

New Findings from Omsk State Pedagogical University in the Area of Breast Cancer Published (Salivary Tryptophan as a Metabolic Marker of HER2-Negative Molecular Subtypes of Breast Cancer)

• Source: Women's Health Weekly. May 16, 2024, 661

Record details

Researcher at Baskent University School of Medicine Has Published New Data on Personalized Medicine (Metastatic progression of breast cancer along with decreased mitochondrial cell death priming of breast cancer cells: a case report)

• Source: Women's Health Weekly. April 11, 2024, 5488

Record details

Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin After Prior Immuno-Oncology or Antibody-Drug Conjugate Therapy

• Authors : Goyal, Ravi K.; Zhang, Jingchuan; Davis, Keith L.

• Source: Breast Cancer: Targets and Therapy. November 30, 2023, Vol. 15, p855, 10 p.

Record details

Predictors of successful neoadjuvant treatment in HER2-positive breast cancer

• Authors : Hannikainen, Elli-Noora; Mattson, Johanna; Karihtala, Peeter

• Source: Oncology Letters. October, 2023, Vol. 26 Issue 4, p1r, p7 p.

Record details

Invasive Breast Cancer with HER2 [greater than or equal to]4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing

• Authors : Bai, Qianming; Lv, Hong; Bao, Longlong

• Source: Breast Cancer: Targets and Therapy. August 31, 2023, Vol. 15, p563, 13 p.

Record details

Patient-derived response estimates from zero-passage organoids of luminal breast cancer

• Source: Women's Health Weekly. April 11, 2024, 3968

Record details